Switch theme
Sign up to access all valuation multiples
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. Its healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
2001
9.2K+
LTM Revenue $1.5B
LTM EBITDA $276M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Terveystalo has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $276M.
In the most recent fiscal year, Terveystalo achieved revenue of $1.5B and an EBITDA of $244M.
Terveystalo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Terveystalo valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $642M | XXX | $888M | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 59% | XXX | XXX | XXX |
| EBITDA | $276M | XXX | $244M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $168M | XXX | $134M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $97.6M | XXX | $80.5M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $352M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Terveystalo's stock price is EUR 12 (or $14).
Terveystalo has current market cap of EUR 1.5B (or $1.7B), and EV of EUR 2.0B (or $2.3B).
See Terveystalo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.3B | $1.7B | XXX | XXX | XXX | XXX | $0.79 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Terveystalo has market cap of $1.7B and EV of $2.3B.
Terveystalo's trades at 1.5x EV/Revenue multiple, and 9.3x EV/EBITDA.
Equity research analysts estimate Terveystalo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Terveystalo has a P/E ratio of 17.6x.
See valuation multiples for Terveystalo and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBIT | 13.6x | XXX | 17.0x | XXX | XXX | XXX |
| EV/Gross Profit | 3.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 17.6x | XXX | 21.4x | XXX | XXX | XXX |
| EV/FCF | 14.2x | XXX | 11.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTerveystalo's last 12 month revenue growth is 2%
Terveystalo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Terveystalo's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Terveystalo's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Terveystalo and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 68% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Terveystalo acquired XXX companies to date.
Last acquisition by Terveystalo was XXXXXXXX, XXXXX XXXXX XXXXXX . Terveystalo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Terveystalo founded? | Terveystalo was founded in 2001. |
| Where is Terveystalo headquartered? | Terveystalo is headquartered in Finland. |
| How many employees does Terveystalo have? | As of today, Terveystalo has 9.2K+ employees. |
| Who is the CEO of Terveystalo? | Terveystalo's CEO is Mr. Ville Iho. |
| Is Terveystalo publicy listed? | Yes, Terveystalo is a public company listed on HEL. |
| What is the stock symbol of Terveystalo? | Terveystalo trades under TTALO ticker. |
| When did Terveystalo go public? | Terveystalo went public in 2017. |
| Who are competitors of Terveystalo? | Similar companies to Terveystalo include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Terveystalo? | Terveystalo's current market cap is $1.7B |
| What is the current revenue of Terveystalo? | Terveystalo's last 12 months revenue is $1.5B. |
| What is the current revenue growth of Terveystalo? | Terveystalo revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Terveystalo? | Current revenue multiple of Terveystalo is 1.5x. |
| Is Terveystalo profitable? | Yes, Terveystalo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Terveystalo? | Terveystalo's last 12 months EBITDA is $276M. |
| What is Terveystalo's EBITDA margin? | Terveystalo's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Terveystalo? | Current EBITDA multiple of Terveystalo is 8.3x. |
| What is the current FCF of Terveystalo? | Terveystalo's last 12 months FCF is $160M. |
| What is Terveystalo's FCF margin? | Terveystalo's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Terveystalo? | Current FCF multiple of Terveystalo is 14.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
